These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33774769)

  • 1. ASO Author Reflections: Previous History of Non-urothelial Malignancy May Provide Predictive Information of Worse Clinical Outcome for Initially Diagnosed Non-Muscle Invasive Bladder Cancer.
    Kufukihara R; Kikuchi E; Ogihara K; Shigeta K; Oya M
    Ann Surg Oncol; 2021 Sep; 28(9):5360-5361. PubMed ID: 33774769
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: Dialysis and Recurrence in Urothelial Cancer.
    Lin MY; Hwang SJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):978-979. PubMed ID: 30374918
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer.
    Kufukihara R; Kikuchi E; Ogihara K; Shigeta K; Yanai Y; Takamatsu K; Ide H; Oyama M; Asakura H; Mizuno R; Oya M
    Ann Surg Oncol; 2021 Sep; 28(9):5349-5359. PubMed ID: 33666810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder.
    Golabesk T; Palou J; Rodriguez O; Parada R; Skrobot S; Peña JA; Villavicencio H
    Urology; 2017 Feb; 100():145-150. PubMed ID: 27765584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?
    Kotb AF; Kovac E; Kassouf W; Chin J; Fradet Y; Izawa J; Estey E; Fairey A; Rendon R; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Drachenberg D; Aprikian AG
    World J Urol; 2012 Dec; 30(6):761-7. PubMed ID: 22293934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Donat SM; Bochner BH; Dalbagni G
    J Urol; 2013 Oct; 190(4):1187-91. PubMed ID: 23680310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
    Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial malignancy--much promise but little progress.
    Bahnson RR
    J Urol; 1996 Jan; 155(1):122. PubMed ID: 7490807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guideline on urothelial carcinoma of the bladder].
    Bevers RF; Battermann JJ; Gietema JA; Hulsbergen-Van de Kaa CA; de Reijke TM; Feller N; Witjes JA; ;
    Ned Tijdschr Geneeskd; 2009; 153():A956. PubMed ID: 20051162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence.
    Rodriguez Faba O; Gaya JM; Breda A; Juarez Del Dago P; Pisano F; Salas D; Palou J
    J Urol; 2016 Jul; 196(1):52-6. PubMed ID: 26802584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Bladder Urothelial Neoplasm in Renal Transplant Recipients: A Retrospective, Multicentered Study.
    Palazzetti A; Bosio A; Dalmasso E; Destefanis P; Fop F; Pisano F; Segoloni G; Biancone L; Volpe A; Di Domenico A; Terrone C; Iesari S; Famulari A; Todeschini P; Frea B; Gontero P
    Urol Int; 2018; 100(2):185-192. PubMed ID: 29342465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers.
    Kim KH; Lee SH; Kim SI; Chung BH; Koo KC; Cho JS; Bang WJ; Park JY; Hong SJ
    Urol J; 2019 Dec; 16(6):558-562. PubMed ID: 30882164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
    Mori K; Schuettfort VM; Egawa S; Compérat E; Shariat SF
    Ann Surg Oncol; 2022 Aug; 29(8):5317-5318. PubMed ID: 35412203
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
    Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L
    Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.